Helus Pharma Inc. Common Stock HELP
$11.80
+10.07%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $45.00
- Implied Upside
- +281.4%
- Price Target Range
- $16.00 – $70.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-18 | BarclaysEmily Field |
Initiates coverage on | Overweight | $35 |
| 2026-08-20 | TD CowenRitu Baral |
Maintains | Buy | $8 → $62 |
| 2026-07-27 | Wells FargoBenjamin Burnett |
Initiates coverage on | Overweight | $16 |
| 2026-07-09 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $95 → $70 |
| 2026-07-01 | Canaccord GenuitySumant Kulkarni |
Maintains | Buy | $45 → $42 |
| 2026-04-13 | TD CowenRitu Baral |
Initiates coverage on | Buy | $8 |
| 2026-03-02 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $55 → $95 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $11.80
- Market Cap
- $862.22 million
- 52-Week Range
- $3.76 – $15.15
- Average Volume
- 1.61 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.